Omnicell Inc

$134.38 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Omnicell Inc

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Stock Analysis

last close $133.68
1-mo return 8.2%
3-mo return 10.4%
avg daily vol. 500.53T
52-week high 146
52-week low 56.16
market cap. $5.8B
forward pe 38
annual div. -
roe 3.6%
ltg forecast 15%
dividend yield -
annual rev. $892M
inst own. -
baraka

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist